GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eutilex Co Ltd (XKRX:263050) » Definitions » EV-to-EBITDA

Eutilex Co (XKRX:263050) EV-to-EBITDA : -2.73 (As of Jun. 08, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eutilex Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Eutilex Co's enterprise value is ₩59,142.1 Mil. Eutilex Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-21,675.8 Mil. Therefore, Eutilex Co's EV-to-EBITDA for today is -2.73.

The historical rank and industry rank for Eutilex Co's EV-to-EBITDA or its related term are showing as below:

XKRX:263050' s EV-to-EBITDA Range Over the Past 10 Years
Min: -68.7   Med: -14.99   Max: -1.99
Current: -2.73

During the past 9 years, the highest EV-to-EBITDA of Eutilex Co was -1.99. The lowest was -68.70. And the median was -14.99.

XKRX:263050's EV-to-EBITDA is ranked worse than
100% of 450 companies
in the Biotechnology industry
Industry Median: 9.385 vs XKRX:263050: -2.73

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-08), Eutilex Co's stock price is ₩2100.00. Eutilex Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-724.000. Therefore, Eutilex Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Eutilex Co EV-to-EBITDA Historical Data

The historical data trend for Eutilex Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eutilex Co EV-to-EBITDA Chart

Eutilex Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only -30.63 -21.09 -12.74 -6.53 -3.90

Eutilex Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.08 -3.77 -2.81 -3.90 -3.87

Competitive Comparison of Eutilex Co's EV-to-EBITDA

For the Biotechnology subindustry, Eutilex Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eutilex Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eutilex Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Eutilex Co's EV-to-EBITDA falls into.



Eutilex Co EV-to-EBITDA Calculation

Eutilex Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=59142.119/-21675.775
=-2.73

Eutilex Co's current Enterprise Value is ₩59,142.1 Mil.
Eutilex Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-21,675.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eutilex Co  (XKRX:263050) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Eutilex Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2100.00/-724.000
=At Loss

Eutilex Co's share price for today is ₩2100.00.
Eutilex Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-724.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Eutilex Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Eutilex Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Eutilex Co (XKRX:263050) Business Description

Traded in Other Exchanges
N/A
Address
Daeryung Technotown 17, Suite 1401, Gasan Digital 1-ro 25, Geumcheon-gu, Seoul, KOR, 08594
Eutilex Co Ltd is a Korean that operates in the anti-tumor immunotherapy market. The company develops anti-tumor T cell therapy and antibody therapeutics based on its immunotherapy technology. Its pipeline products include T Cell Therapy (4-1BB CTL), CAR-T, and Antibody.

Eutilex Co (XKRX:263050) Headlines

No Headlines